InterVene, Inc. — Form D
InterVene, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-07. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-03-07
- Form: D
- Accession: 0001567619-23-004526
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.5M
- Remaining: $1.5M
- Investors: 6
- Date of first sale: 2023-02-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-475025
Issuer
- Name: InterVene, Inc.
- CIK: 0001637074
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 415 Grand Avenue, Suite 302, South San Francisco, CA, 94080
- Phone: 650-351-6725
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Fletcher Wilson | Director | Derry, NH |
| Fletcher Wilson | Executive Officer | Derry, NH |
| Thomas Fogarty | Director | Albany, NY |
| Adam Berman | Director | Austin, TX |
| Mel Schatz | Director | Carmel, IN |
| Ginger Glaser | Director | South San Francisco, CA |
| Jay Schmelter | Director | South San Francisco, CA |
| Catherine L Matthes | Executive Officer | South San Francisco, CA |
| Joe Biller | Director | South San Francisco, CA |
| Jeffrey Elkins | Director | South San Francisco, CA |
| Jeffrey Elkins | Executive Officer | South San Francisco, CA |
| Evan Ng | Executive Officer | Santa Clara, CA |
Other filings by this issuer (3)
More